Arcadia Biosciences (RKDA) Tops Q2 EPS by 2c, Miss on Revenues

Arcadia Biosciences (NASDAQ: RKDA) reported Q2 EPS of ($0.09), $0.02 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $991 thousand versus the consensus estimate of $1.3 million.

For earnings history and earnings-related data on Arcadia Biosciences (RKDA) click here.

You May Also Be Interested In

• Arcadia Biosciences (RKDA) Announces Second Quarter and First Half 2026 Financial Results and Business Highlights
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Newton Golf Company (NWTG) Reports Q2 Loss of $0.49